How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

The Council for the Indian School Certificate Examinations (CISCE) has released the ISC Computer Science (Subject Code - 868) for the Year 2027 evaluation cycle. It is designed specifically to make ...

Model collapse AI training data risk grows as Meta’s Brand Memory ad tools flood the open web with synthetic content, ...

As AI transforms education, we must redefine intelligence beyond biological limits and embrace cognitive functions across ...

The rise of AI has brought an avalanche of new terms and slang. Here is a glossary with definitions of some of the most ...

In Barrie's Peter Pan, Wendy sewed Peter's mischievous shadow back on his feet. Wendy saw what was incomplete and chose to ...

Drug discovery has long been a slow, expensive process of trial and error, and for a small clinical-stage company, every wasted experiment is capital it can scarcely afford. That is the backdrop for a ...

Abstract: In this article, we describe a deterministic optimization framework for the conceptual-stage design of aerodynamically-actuated wingsails. The primary objective of high-performance sailing ...

Abstract: Secondary control in autonomous DC microgrids is essential for bus voltage recovery and ensuring proper current sharing, yet often fails to enforce strict state constraints during large ...

"Our mission at Longevity Investors is to connect the people shaping the future of human health and longevity — investors, entrepreneurs, scientists, family offices, and industry leaders." ...

In the AI value chain, application-layer leaders like Palantir and ServiceNow may win long term as chip/cloud margins ...

New VentureBeat survey data: 85% of enterprises run contested AI platforms with no single owner, and only 10% can ...